Recruiting
Study of Intra-Arterial Infusion of Lutetium (177Lu) Oxodotreotide for Adults with Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases
Registered drugNo placebo
Study of Intra-Arterial Infusion of Lutetium (177Lu) Oxodotreotide for Adults with Gastroenteropancreatic Neuroendocrine Tumors with Liver Metastases
Registered drugNo placebo
- Disease:Gastroenteropancreatic neuroendocrine tumour disease
- Substances:Amlodipine BesilateEdotreotide+10
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Amlodipine Besilate
